V7Y-34710-30948
2 vaccinations
2 coded responses
17 check-ins
2 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 770 / TX
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- American Indian or Alaska Native
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-29
Registered in v-safe
-
2021-01-29
Dose 1 — Pfizer-BioNTech
- 2021-01-29
- 2021-01-31
-
2021-02-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Chills, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-01
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-02-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-02
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-02-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-04
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-02-05
Health check-in — day 7, dose 1Feeling: Good · Fatigue or tiredness, Diarrhea · Be unable to workAdult check-in
- 2021-02-05
- 2021-02-12
- 2021-02-19
-
2021-02-24
Dose 2 — Pfizer-BioNTech
-
2021-02-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache · Be unable to workAdult check-in
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
-
2021-03-03
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: FairFree text: Lymph nodes in the armpitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-10
- 2021-03-17
-
2021-08-25
Survey response — 6 months, dose 2MedDRA: Diarrhoea — Feeling: FairFree text: DiarrheaMedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-24 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-01 | priority 2/3 | |
| 2021-02-02 | priority 2/3 | |
| 2021-02-04 | priority 2/3 | |
| 2021-02-05 | priority 2/3 |
Free text
Release 5 — day 7, dose 2
Systemic reaction (other): Lymph nodes in the armpit
Release 9 — 6 months, dose 2
Symptoms: Diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | ✓ | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release